Abstract

Keywords: diffuse large B-cell lymphoma; cell of origin; genetic alterations; double hit; double expresser; MYC; BCL2; BCLU

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
CAR-T Therapy in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Real World Outcomes Based on Tumor Biology
Luke Brinkman ... Sagar S Patel
Blood | VOL. 140
Luke Brinkman, et. al.Luke Brinkman ... Sagar S Patel
15 Nov 2022
Molecular Subtype Characterization of Formalin-Fixed, Paraffin-Embedded Diffuse Large B-Cell Lymphoma Samples on the Iceplex® System.
Angela M.B Collie ... Eric D Hsi
Blood | VOL. 120
Angela M.B Collie, et. al.Angela M.B Collie ... Eric D Hsi
16 Nov 2012
Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system.
Angela M B Collie ... Thomas Daly
British journal of haematology | VOL. 167
Angela M B Collie, et. al.Angela M B Collie ... Thomas Daly
25 Jun 2014
First-Mind: Primary Analysis from a Phase Ib, Open-Label, Randomized Study to Assess Safety of Tafasitamab or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
David Belada ... Grzegorz S Nowakowski
Blood | VOL. 138
David Belada, et. al.David Belada ... Grzegorz S Nowakowski
05 Nov 2021
View more papers

More From: Hematological oncology

Paper Title
Journal
Date
Author
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
Danai Dima ... Jack Khouri
Hematological oncology | VOL. 42
Danai Dima, et. al.Danai Dima ... Jack Khouri
01 Jul 2024
Prescription patterns of venetoclax in acute myeloid leukemia.
Andrealuna Ucciero ... Monia Lunghi
Hematological oncology | VOL. 42
Andrealuna Ucciero, et. al.Andrealuna Ucciero ... Monia Lunghi
01 Jul 2024
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Enrica Antonia Martino ... Concetta Conticello
Hematological oncology | VOL. 42
Enrica Antonia Martino, et. al.Enrica Antonia Martino ... Concetta Conticello
01 Jul 2024
Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1year in a hematology department of teaching hospital.
Caroline Le Lan ... Hervé Ghesquieres
Hematological oncology | VOL. 42
Caroline Le Lan, et. al.Caroline Le Lan ... Hervé Ghesquieres
01 Jul 2024
View more papers